Harnessing regulatory T cells to establish immune tolerance.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38478632.
- Also identified by DOI 10.1126/scitranslmed.adm8859.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Engineered regulatory T (T<sub>reg</sub>) cells have emerged as precision therapeutics aimed at inducing immune tolerance while reducing the risks associated with generalized immunosuppression. This Viewpoint highlights the opportunities and challenges for engineered T<sub>reg</sub> cell therapies in treating autoimmune and other inflammatory diseases.
Medical subject headings
- T-Lymphocytes, Regulatory
- Autoimmune Diseases